Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 25, 2022

BUY
$204.13 - $302.4 $63,688 - $94,348
312 Added 5.59%
5,895 $1.26 Million
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $257,298 - $364,644
1,007 Added 22.01%
5,583 $1.59 Million
Q4 2021

Jan 18, 2022

BUY
$351.38 - $448.68 $1.61 Million - $2.05 Million
4,576 New
4,576 $1.73 Million
Q4 2020

Feb 02, 2021

SELL
$222.0 - $252.62 $572,760 - $651,759
-2,580 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$175.56 - $226.45 $452,944 - $584,241
2,580 New
2,580 $583,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.